A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus

Clinical trial NCT07405970 · RECRUITING

Trial details

NCT number: NCT07405970
Sponsor: Beijing Mabworks Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2026-04-10
Primary completion: 2028-12-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.